HF
AXNX

HRT Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

HRT Financial’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,838
Closed -$345K – 3278
2023
Q2 		$345K Sell
6,838
-35,508
-84% -$1.89M ﹤0.01% 1543
2023
Q1 		$2.31M Buy
+42,346
New +$2.47M 0.03% 528

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

HRT Financial's AXNX Position: Q3 2023 in Review

HRT Financial sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 6,838 shares — an estimated $345K sold.

HRT Financial first reported a position in AXNX in Q1 2023 and held it in 2 quarters. The position peaked at $2.31M in Q1 2023. 221 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

  • HRT Financial reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 6,838 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $345K.
  • HRT Financial first reported a position in Axonics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
  • HRT Financial's Axonics, Inc. Common Stock position peaked at $2.31M in Q1 2023.
  • 221 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.